CXCR4 Has a CXCL12-Independent Essential Role in MLL-AF9 Driven Acute Myeloid Leukemia

被引：0
|
作者：
Ramakrishnan, Ramprasad [1 ]
Pena-Martinez, Pablo [1 ]
Agarwal, Puneet [2 ]
Hogberg, Carl [1 ]
Chapellier, Marion [1 ]
Shah, Mansi [2 ]
Nilsson, Bjorn [3 ]
Ebert, Benjamin L. [4 ]
Bhatia, Ravi [2 ]
Jaras, Marcus [1 ]
机构：
[1] Lund Univ, Div Clin Genet, Dept Lab Med, Lund, Sweden
[2] Univ Alabama Birmingham, Div Hematol Oncol, Birmingham, AL 35294 USA
[3] Lund Univ, Div Hematol & Transfus Med, Lund, Sweden
[4] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116137
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
774
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR
    G Mitterbauer
    C Zimmer
    C Fonatsch
    OA Haas
    R Thalhammer-Scherrer
    I Schwarzinger
    P Kalhs
    U Jaeger
    K Lechner
    C Mannhalter
    Leukemia, 1999, 13 : 1519 - 1524
  • [22] Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR
    Mitterbauer, G
    Zimmer, C
    Jaeger, U
    Fonatsch, C
    Lechner, K
    Mannhalter, C
    BLOOD, 1998, 92 (10) : 203B - 203B
  • [23] Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR
    Mitterbauer, G
    Zimmer, C
    Fonatsch, C
    Haas, OA
    Thalhammer-Scherrer, R
    Schwarzinger, I
    Kahls, P
    Jaeger, U
    Lechner, K
    Mannhalter, C
    LEUKEMIA, 1999, 13 (10) : 1519 - 1524
  • [24] The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Gualberto, Antonio
    Scholz, Catherine
    Janes, Matthew R.
    Kessler, Linda
    Raza, Azra
    BLOOD, 2017, 130
  • [25] Significance of CXCL12/CXCR4 Ligand/Receptor Axis in Various Aspects of Acute Myeloid Leukemia
    Yazdani, Zinat
    Mousavi, Zahra
    Moradabadi, Alireza
    Hassanshahi, Gholamhossein
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2155 - 2165
  • [26] The role of CXCL12 in acute lymphoblastic leukemia in vivo: Potential therapeutic role for CXCR4 antagonists
    Bendall, L. J.
    Juarez, J.
    Dela Pena, A.
    Baraz, R.
    Hewson, J.
    Cisterne, A.
    Bradstock, K. F.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 45 - 46
  • [27] HIGH IGSF4 EXPRESSION DISCRIMINATIVE FOR MLL-AF9 PEDIATRIC ACUTE MYELOID LEUKEMIA WITH FAB M5
    Coenen, Eva
    Kuipers, Jenny E.
    Coenen, Eva A.
    Balgobind, Brian V.
    Pieters, Rob
    Stary, Jan
    Baruchel, Andre
    de Haas, Valerie
    de Bont, Eveline S. J. M.
    Reinhardt, Dirk
    Kaspers, Gertjan J. L.
    Marschalek, Rolf
    Meyer, Claus
    Zwaan, C. Michel
    van den Heuvel-Eibrink, Marry M.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 819 - 819
  • [28] Structural Basis for MLL Cxxc Domain Protection against CpG DNA Methylation and the Essential Role of This Function in MLL-AF9 Leukemia
    Risner, Laurie
    Cierpicki, Tomasz
    Grembecka, Jolanta
    Lukasik, Stephen M.
    Popovic, Relja
    Shultis, David S.
    Zeleznik-Le, Nancy J.
    Bushweller, John H.
    BLOOD, 2009, 114 (22) : 317 - 317
  • [29] Transformation from acute promyelocytic leukemia in pregnancy to acute myeloid leukemia with MLL-AF9 fusion gene: A case report and literature review
    Gao, Yang
    Han, Na
    Jiang, Yu
    Lu, Ziyuan
    MEDICINE, 2023, 102 (48)
  • [30] Continued expression of the NRAS(G12V) oncogene is required for the maintenance of acute myeloid leukemia induced in cooperation with MLL-AF9
    Kim, Won-Il
    Matise, Ilze
    Diers, Miechaleen
    Largaespada, David
    BLOOD, 2007, 110 (11) : 482A - 482A
12345